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Abstract
Importance
Medicare beneficiaries with high medical needs can benefit from Advance Care Planning
(ACP). Medicare reimburses clinical providers for ACP discussions, but it is unknown
whether high-need beneficiaries are receiving this service.
Objective
To compare rates of billed ACP discussions among a cohort of high-need Medicare benefi-
ciaries with the non-high-needs Medicare population.
Design
Retrospective analysis of Medicare Fee-for-Service (FFS) claims in 2017 comparing high-
need beneficiaries (seriously ill, frail, ESRD, and disabled) with non-high need beneficiaries.
Setting
Nationally representative FFS Medicare 20% sample
Participants
Medicare beneficiaries were assigned to one of the following classifications: seriously ill (65
+), frail (65+), seriously ill & frail (65+); non-high need (65+); end stage renal disease
(ESRD) or disabled (<65). All participants had data available for years 2016–2017.
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Exposure
Receipt of a billed ACP discussion, CPT codes 99497 or 99498.
Main outcome and measure
Rates of billed ACP visits were compared between high-need patients and non-high-need
patients. Rates were adjusted for the 65+ population for sex, age, race/ethnicity, Charlson
comorbidity index, Medicare/Medicaid dual eligibility status, and Hospital Referral Region.
Results
Among the 65+ groups, those most likely to have a billed ACP discussion included seriously
ill & frail (5.2%), seriously ill (4.2%), and frail (3.3%). Rates remained consistent after adjust-
ing (4.5%, 4.0%, 3.1%, respectively). Each subgroup differed significantly (p < .05) from
non-high need beneficiaries (2.3%) in both unadjusted and adjusted analyses. Among the
<65 high need groups, the rates were 2.7% for ESRD and 1.3% for the disabled (the latter
p < .05 compared with non-high needs).
Conclusions and relevance
While rates of billed ACP discussions varied among patient groups with high medical needs,
overall they were relatively low, even among a cohort of patients for whom ACP may be
especially relevant.
Introduction
Advance Care Planning (ACP) aims to align medical treatment to patients’ values, goals and
preferences for care during serious and chronic illness.[1],[2] Medicare is the United States
federal health insurance program designed to cover individuals over age 65, and under age 65
who have a qualifying disability or end-stage renal disease (ESRD). Effective January 1, 2016,
Medicare (CMS) reimburses clinical providers for ACP. Discussions eligible for reimburse-
ment by Medicare include explanation and discussion of advance directives such as standard
forms, which may result in documentation of patient preferences for end-of-life (EOL) treat-
ment. ACP includes a discussion between a qualified healthcare provider and a patient, and is
an important component of care management. Medicare does not require any specific benefi-
ciary diagnosis to reimburse for ACP discussions, and any beneficiary is entitled to the service.
A review of best practices of serious illness care communication defined ACP “high value care
advice” as conversations that should begin as early as possible in the course of serious or life-
limiting illnesses. Care management is especially complex for “high-need” patients, who face a
combination of high healthcare costs, utilization intensity, and functional limitations. A recent
analysis of interventions and policies related to ACP recommended a focus on the seriously ill
to improve value of care towards the end of life.[3] Given that roll-out of ACP billing proce-
dures may require investment of time and money by health systems, timing ACP strategically
via prognostic stratification of patients can help to identify groups at higher risk for facing
end-of-life decisions, [4] and may improve quality of life, family outcomes, and reduce costs.
[5],[6] Prior research on uptake of the ACP billing codes [7],[8] has not addressed these
patients. This analysis therefore examined rates of billed ACP discussions among a national
ACP among high-need Medicare beneficiaries in 2017
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cohort of high-need Medicare patients compared with Medicare beneficiaries not identified as
high need. We hypothesized that high needs patients of all types would have higher rates of
billed ACP discussions than other patients.
Methods
Population
The Partners Human Research Committee reviewed this research and determined it is "not
human research", approval protocol number 2017P000371/PHS. We used the 20% sample of
Fee-For-Service (FFS) Medicare beneficiaries from 2016–2017. Beneficiary characteristics
were obtained from the Medicare beneficiary summary file. We used claims in 2016 to identify
high-need patients and claims in 2017 for receipt of a billed ACP visit. Beneficiaries alive in
2017 were categorized into six (6) mutually exclusive groups, stratified by age: 1) seriously ill
only age 65+ (SI) 2) frail only 65+ (F); 3) beneficiaries who are both frail and seriously ill 65+
(F&SI); 4) non-high-need 65+; 5) disabled<65; 6) end-stage renal disease (ESRD) <65. The
high needs groups in this analysis are closely aligned with those described by the National
Academy of Medicine (NAM).[9] We excluded beneficiaries whose first billed ACP discussion
occurred in 2016 as the visit may have coincided with the qualifying eligibility criteria.
There is no consensus definition of serious illness.[10] Therefore, we identified criteria for
serious illness using ICD-10 codes to capture patients with a median survival of roughly two
years or less and/or substantial suffering. Focusing on high risk of mortality provides an
opportunity to target patients with persistently high healthcare utilization.[11] We included
the primary and secondary diagnoses of chronic obstructive pulmonary disease (COPD) and
other lung diseases, heart failure, renal failure, cancer, dementia, and neurodegenerative dis-
eases in the cohort (See randomized trials NCT02100566, NCT02487810, NCT02505035,
NCT02017548).
To identify frailty, we adapted the ICD-10 codes from the Claims-based Frailty Index,[12]
including abnormality of gait, abnormal loss of weight, adult failure to thrive, cachexia, debil-
ity, difficulty in walking, history of fall, malaise and fatigue, muscular wasting, muscle weak-
ness, pressure ulcer, and senility without mention of psychosis. In addition, we used HCPCs
codes to capture patients using durable medical equipment. Any beneficiaries with at least two
or more of these ICD-10 codes in 2016 were considered frail.
We used the Disability Insurance Benefits (DIB) and End-Stage Renal Disease (ESRD)
Medicare entitlement to select beneficiaries with a disability or ESRD. Beneficiaries who qual-
ify under age 65 due to a permanent disability have relatively high rates of chronic conditions,
functional limitations, and cognitive impairments[13]. The ESRD category included a small
number of beneficiaries with DIB. We identified these beneficiaries by their “current” status,
so all were under age 65.
Outcomes
The primary outcome was the receipt of one or more billed ACP discussions, defined as having
at least one visit that included either primary Current Procedural Terminology (CPT) code
99497 or 99498 between January 1 and December 31, 2017. CPT codes are used by Medicare
to determine the amount of reimbursement that a practitioner will receive for each service.
Code 99497 reimburses for the first 30 minutes of ACP discussions with patients, family mem-
bers, and/or surrogates, and the add-on secondary code 99498 reimburses for extended time
beyond 30 minutes.
ACP among high-need Medicare beneficiaries in 2017
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Statistics
We conducted the analyses to compare utilization of the ACP billing code for the high-need
groups with all the non-high need population. We first calculated the crude billed ACP discus-
sion rates without adjustment for each group. In the multivariate analysis, we restricted it to
those who were at least age 65 since the comparison group of non-high-needs population was
65+, we further computed the adjusted rates for the seriously ill, frail, seriously ill & frail to all
non-high-need beneficiaries from multivariate logistic regression models approximately by
the SAS LESMEANS statement, after accounting for all potential confounders. Covariates con-
sidered for the 65+ population included sex, age (65–74, 75–84, 85+), race/ethnicity (Non-His-
panic White, Non-Hispanic Black, Hispanic, Asian, other, unknown), Charlson comorbidity
index (CCI) calculated using a 12-month look-back period (0, 1, 2, 3, 4, 5 or more), Medicare/
Medicaid dual eligibility status, and Hospital Referral Region (HRR) level of overall spending.
We categorized HRRs according to total spending from 2012–2016[14], adjusted for race, sex
and age, as ‘high’ (>75th), medium (25 to 75th), and low (<25th) percentiles.
All analyses were conducted using SAS software (version 9.4, SAS, Cary, NC). We adopted
the Pearson’s chi-square test for categorical variables and Wilcoxon’s test for the continuous
variables, to compare the baseline characteristics. Two-sided P-values <0.05 were considered
statistically significant.
Results
Sample
The cohort included 5,766,056 beneficiaries, including non-high-need beneficiaries
(4,085,666), seriously ill (N = 429,841), frail (N = 158,939), seriously ill & frail (N = 172,472),
ESRD (N = 15,596) and disability (N = 903,542). We excluded 30,545 whose first billed ACP
discussion occurred in 2016. Compared to the non-high needs group, higher proportions of
seriously ill, frail, and seriously ill & frail beneficiaries were female and white, while higher pro-
portions of beneficiaries with ESRD or disability were male, Black, and have dual-eligibility
status (Table 1, all p< .05). The CCI was lowest in the disability group. Finally, compared to
non-high-needs beneficiaries, larger proportions of all high-need subgroups except those with
a disability were more likely to reside in higher spending HRRs.
ACP visits
Overall rates of billed ACP discussions were low, 2.4%, in 2017 2.3% among non-high-needs
beneficiaries). ACP billing varied among the 65+ groups, 2.3% of non-high-need beneficiaries
compared to 5.2% of seriously ill & frail, 4.2% of seriously ill, and3.3% of frail beneficiaries.
(See Fig 1). Rates remained consistent after adjusting (4.5%, 4.0%, 3.1%, respectively). Each
subgroup differed significantly (p< .05) from non-high needs beneficiaries in both unadjusted
and adjusted analyses. Among the<65 high needs groups, the rates were 2.7% for ESRD and
1.3% for the disabled (the latter p< .05 compared with non-high needs).
Discussion
We found overall low rates of billed ACP discussions among high needs beneficiaries. Still,
there are important distinctions. Specifically, beneficiaries with a diagnosis of disability or
ESRD were less likely than other high needs groups, and among disabled beneficiaries, even
the average Medicare patient, to receive a billed ACP discussion. By contrast, beneficiaries des-
ignated as seriously ill or frail were more likely than other patients to have a billed ACP
discussion.
ACP among high-need Medicare beneficiaries in 2017
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Beneficiaries who met the criteria for being both frail and seriously ill were potentially the
sickest group, and in fact were the most likely to receive a billed ACP discussion. For the com-
bined seriously ill & frail group, the rate was 5.2% unadjusted, 4.4% adjusted. While these rates
were among the highest in the cohort, they are still relatively low.
ESRD beneficiaries may be an important population group to include in targeted ACP
interventions. A study comparing decedents with ESRD to cancer patients found lower rates
of ACP conversations and higher treatment intensity at the end of life among ESRD patients,
despite similarly high rates of symptoms[15]. ESRD beneficiaries also have been shown to
receive palliative care consultation services less often than other seriously ill patients who have
comparable symptom burdens.[16]
Table 1. Characteristics of included beneficiaries (2017).
All
(N = 5,766,056)
Non-high-needs
(N = 4,085,666)
age 65+ under age 65
SI
(N = 429,841)
Frail
(N = 158,939)
SI & Frail
(N = 172,472)
ESRD
(N = 15,596)
Disability
(N = 903,542)
n % n % n % n % n % n % n %
ACP� 139201 2.4 94,838 2.3 18,204 4.2 5,259 3.3 8,957 5.2 415 2.7 11,528 1.3
Sex
Male 2,597,169 45 1,799,297 44 200,986 46.8 52,152 32.8 65,645 38.1 9,014 57.8 470,075 52
Female 3,168,887 55 2,286,369 55.9 228,855 53.2 106,787 67.2 106,827 61.9 6,582 42.2 433,467 48
Age
<65 873,999 15.2 # # # # # # # # 15,038 96.42 858,961 95
65–74 2,373,812 41.2 2,112,309 51.7 133,434 31 44,821 28.2 38,109 22.1 # # # #
75–84 1,681,963 29.2 1,395,767 34.2 167,002 38.8 57,510 36.2 61,684 35.8 # # # #
> = 85 836,282 14.5 577,590 14.1 129,405 30.1 56,608 35.6 72,679 42.1 # # # #
Race
White, non-Hispanic 4,824,119 83.7 3,510,427 85.9 363,297 84.5 141,214 88.8 149,117 86.5 6,251 40.1 653,813 72.4
Black, non-Hispanic 526,229 9.1 282,209 6.9 41,674 9.7 10,863 6.8 15,979 9.3 6,237 40 169,267 18.7
Asian/North Amer Native 135,853 2.4 96,862 2.4 9,407 2.2 2,578 1.6 2,843 1.6 987 6.3 23,176 2.6
Hispanic/Latino 110,528 1.9 59,537 1.5 7,158 1.7 1,711 1.1 2,313 1.3 1,535 9.8 38,274 4.2
Other 91,129 1.6 71,881 1.8 5,753 1.3 1,578 0.9 1,544 0.9 279 1.8 100,094 1.1
Unknown 78,210 1.4 64,750 1.6 2,552 0.6 995 0.6 676 0.4 307 2 8,918 1
Dual Eligibility Status
No 4607959 79.9 3,662,754 89.6 335,930 78.1 119,540 75.2 112,655 65.3 5,343 34.3 371,065 41.1
Yes 1159374 20.1 422,912 10.3 93,911 21.8 39,399 24.8 59,817 34.7 10,253 65.8 532,477 58.9
Charlson Index
0 3,366,389 58.4 2,718,409 66.5 74,073 17.2 42,631 26.8 7,378 4.3 688 4.4 523,210 57.9
1 1,178,234 20.4 834,206 20.4 77,281 18 48,401 30.4 22,013 12.8 4,033 25.9 192,300 21.3
2 582,517 10.1 335,965 8.2 84,614 19.7 34,389 21.6 32,338 18.7 2,890 18.5 92,321 10.2
3 307,986 5.3 131,667 3.2 73,773 17.2 19,254 12.1 33,524 19.4 2,645 17 47,123 5.2
4 164,811 2.9 46,198 1.1 54,312 12.6 9,162 5.8 28,821 16.7 2,082 13.3 24,236 2.7
5 or above 166,119 2.9 19,221 0.5 65,788 15.3 5,102 3.2 48,398 28.1 3,258 20.9 24,352 2.7
HRR Overall Spending
High 1,499,282 26.1 1,042,454 25.6 133,433 31.1 37,737 23.8 51,948 30.1 5,026 32.6 228674 25.4
Medium 3,161,670 55.1 2,234,112 54.9 230,690 53.9 91,761 57.8 96,939 56.2 8,216 53.4 499952 55.5
Low 1,080,025 18.8 788,883 19.4 64,187 15 29,313 18.5 23,464 13.6 2,153 14 172025 19.1
�ACP = beneficiaries with at least one billed ACP visit in 2017 (in high-need and 20% FFS cohorts# = N/A
HRR refers to Dartmouth Atlas Health Referral Regions, SI = Seriously Ill, ESRD = end stage renal disease. Totals will vary due to missing values
https://doi.org/10.1371/journal.pone.0228553.t001
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Existing research on ACP among disabled Medicare beneficiaries is limited. ACP discus-
sions may be especially complex due to a history of discrimination of people with disabilities
and disparities in their care.[17],[18]
The content of ACP discussions varies across the life and health trajectory, and differences
among these high-need beneficiaries may be driven in part by the diversity of age and health
status within the cohort. In designing interventions to better align care with the goals of high-
need patients during billed ACP discussions, health systems must recognize that different
high-need patient segments require different services and workforce competencies.[9] Thus,
while focusing efforts at increasing ACP among all the identified subgroups is an important
strategy for directing limited resources, the discussions will vary between patients who are seri-
ously ill and may focus on end-of-life issues, and a younger, relatively healthy beneficiary with
a disability who may need to designate a proxy but for whom specific end-of-life decision mak-
ing is less immediately relevant.
Limitations
This study has several limitations. This study relies on claims data, and while initial uptake of
the billing code is low, the absence of an ACP billing code does not mean that an ACP discus-
sion has not occurred. Further, administrative claims data do not provide data on the quality
of the discussion, and we cannot assess whether care provided was congruent with patient’s
wishes via claims data alone. Finally, further research is needed to determine whether ACP dis-
cussions impact the course of care.
Conclusions
While rates of billed ACP discussions vary among high-need Medicare beneficiaries based on
categories of high need, overall use of the code remains low. Further examination of ACP bill-
ing codes may be helpful in targeting healthcare resources to improve ACP among high need
patients.
Fig 1. Rates of ACP visits among high-need and non-high need Medicare beneficiaries (2017.
https://doi.org/10.1371/journal.pone.0228553.g001
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ACP discussions should reflect an individual’s health and personal preferences. When
implementing system-wide strategies to build capacity and increase ACP discussions, provid-
ers should be equipped with appropriate training in communication informed by best prac-
tices guidelines.[5] Health systems can improve care for high-need patients by prioritizing
these subgroups for ACP discussions, but should ensure that the distinct needs between
patients are accommodated.
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